The 5th World ADC Summit South Korea (formerly World ADC Asia) is uniting 300+ C-level executives, directors, vice presidents, and scientists from discovery all the way to CMC from leading global ADC companies.
Whether you are focused on innovating dual payloads or developing your own novel payloads, want to improve your preclinical studies through the selection of key biomarkers, analyse key clinical data on novel ADC technologies, streamline your manufacturing processes and partnerships with CDMOs, or improve purity and potency characterisation of your ADC product, this conference has it all.
This is the only ADC meeting in South Korea dedicated to bringing together global leaders from across the ADC industry with end-to-end industry knowledge. This is a must-attend meeting for anyone in South Korea looking to further their ADC development to be first and best-in-class.
Unmissable Event Highlights
Hear the perspectives of local ADC developers on the current development in ADCs and innovation within South Korea to establish the country as the hub of ADC development with Aimed Bio, Pinot Bio & Kanaph Therapeutics
Bridge the gap between two modalities of targeted protein degradation (TPD) and ADC to ensure tumor targeting and potent tumor activity with Orum Therapeutics
Combine precision and potency with dual payload ADCs and enzymatic site-specific conjugation for DAR optimization and improved stability with OBI Pharma
Explore the combination of ADC with immunotherapy to enhance anti-tumor activity and unlock transformative benefit with Pfizer
Validate novel proteasome inhibitor payloads as a first-in-class mechanistic strategy to broaden the payload landscape of next-generation ADCs with Qurient
Divide & Conquer: End-to-End Content for Everyone Working in ADCs
Whether you are exploring the field or have over a decade of experience, are attending to understand the fundamentals, or stay up to date with scientific trends and gain technical insights to enhance your day-to-day work - tailor the World ADC Summit South Korea experience to meet your specific needs with forward-thinking, industry-led content spanning:
Pre-Conference Day
Main Conference Days
Introduction to ADCs Day
Providing a comprehensive overview of the fundamentals of ADC development, covering the history of the field, conjugation strategies, linker-payload basics, and antibody formats.
The agenda is designed to establish a solid foundational understanding of ADCs prior to the end-to-end conference day program.
View full event guide for session details.
Bispecific ADCs Day
Delivering key scientific and technical updates in the rapidly evolving area of bispecific ADCs. Topics include the drivers behind innovation and the science behind target selection, conjugation strategies, and the manufacturing of bispecific ADCs.
Leave this day with all the knowledge you might need to develop your own successful and clinically viable Bispecific ADC.
Track 1:
Discovery
With novel technologies being the biggest focus for Korean developers, understanding the discovery and research behind them is critical to understanding where success lies.
This track will provide you with key updates on latest innovations on novel payloads such as proteasome inhibitors, novel conjugates like degrader-antibody conjugates, photo-cleavable linkers, ITGB6 targeting ADCs and more.
Track 2:
Preclinical & Clinical
While having R&D updates on novel technologies is important, it is also crucial to understand the progress in preclinical and clinical studies of the same as well as gain key updates on traditional ADCs.
Join this track to get clinical updates on novel target ADCs, understand the impact on PK studies, uncover predictive biomarkers for Top1i and more.
Track 3:
CMC
Manufacturing is a crucial step in the process of ADC development and streamlining manufacturing can help reduce long timelines and high costs.
Join this track to improve CDMO selection, overcome complexity of manufacturing associated with novel ADC technologies, optimize purity and potency testing and more.
Download the Official Agenda to Explore:
- Your One-Stop Forum to Develop First- and Best-in-Class ADC Therapeutics
- Insights from 35+ Korean-Based and International Speakers
- Unrivalled Networking Opportunities with Professionals Working on ADCs, TPD & Induced Proximity, and Bispecifics & T-Cell Engagers
Attending Companies Include
Explore the Agenda
Hear the latest ADC technology innovations taking place within South Korea and gain exclusive insights on the progress in ADC development globally.
Partner With Us
Position yourself alongside other leading solution providers to ensure your company is the go-to service providers for Korean ADC leaders.
Join Biopharma Experts
Be part of the hottest conversations with like-minded scientists, C-level executives, heads, managers, VPs, and more across discovery, clinical and CMC functions.